 Teva Pharmaceutical Industries Ltds NYSE: TEVA U.S. affiliate and MedinCell SA OTC: MDCLF have received FDA Complete Response Letter CRL regarding TV-46000mdc-IRM for schizophrenia. The drug candidate is risperidone extended-release injectable suspension for. 